BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25880660)

  • 1. Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility.
    Elkhenini HF; Davis KJ; Stein ND; New JP; Delderfield MR; Gibson M; Vestbo J; Woodcock A; Bakerly ND
    BMC Med Inform Decis Mak; 2015 Feb; 15():8. PubMed ID: 25880660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
    Kern DM; Davis J; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F
    Respir Res; 2015 Apr; 16(1):52. PubMed ID: 25899176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
    Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
    Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring safety in a phase III real-world effectiveness trial: use of novel methodology in the Salford Lung Study.
    Collier S; Harvey C; Brewster J; Bakerly ND; Elkhenini HF; Stanciu R; Williams C; Brereton J; New JP; McCrae J; McCorkindale S; Leather D
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):344-352. PubMed ID: 27804174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J; Dik N; Bugden S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care.
    Thomas M; Radwan A; Stonham C; Marshall S
    COPD; 2014 Jun; 11(3):300-9. PubMed ID: 24152210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
    van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
    BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial.
    Harries TH; Gilworth G; Corrigan CJ; Murphy P; Hart N; Thomas M; White PT
    BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36041773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illustrating the patient journey through the care continuum: Leveraging structured primary care electronic medical record (EMR) data in Ontario, Canada using chronic obstructive pulmonary disease as a case study.
    Rayner J; Khan T; Chan C; Wu C
    Int J Med Inform; 2020 Aug; 140():104159. PubMed ID: 32473567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.
    Sperrin M; Webb DJ; Patel P; Davis KJ; Collier S; Pate A; Leather DA; Pimenta JM
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1369-1376. PubMed ID: 31385428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.